These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

601 related articles for article (PubMed ID: 17375639)

  • 21. Intentional ablation of vestibular function using commercially available topical gentamicin-betamethasone eardrops in patients with Meniere's disease: further evidence for topical eardrop ototoxicity.
    Kaplan DM; Hehar SS; Bance ML; Rutka JA
    Laryngoscope; 2002 Apr; 112(4):689-95. PubMed ID: 12150525
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of Ménière's disease by intratympanic gentamicin application.
    Assimakopoulos D; Patrikakos G
    J Laryngol Otol; 2003 Jan; 117(1):10-6. PubMed ID: 12590850
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Intratympanic gentamicin treatment for intractable Menière's disease].
    Gilony D; Wolf M; Kronenberg J
    Harefuah; 2004 Jan; 143(1):4-7, 88. PubMed ID: 14748278
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term results after interval therapy with intratympanic gentamicin for Menière's disease.
    Lange G; Maurer J; Mann W
    Laryngoscope; 2004 Jan; 114(1):102-5. PubMed ID: 14710003
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of the round window microcatheter in the treatment of Meniere's disease.
    Hoffer ME; Kopke RD; Weisskopf P; Gottshall K; Allen K; Wester D; Balaban C
    Laryngoscope; 2001 Nov; 111(11 Pt 1):2046-9. PubMed ID: 11801994
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High-dose intratympanic gentamicin instillations for treatment of Meniere's disease: long-term results.
    Hsieh LC; Lin HC; Tsai HT; Ko YC; Shu MT; Lin LH
    Acta Otolaryngol; 2009 Dec; 129(12):1420-4. PubMed ID: 19922092
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Curative effect of transtympanic perfusion of gentamicin on unilateral Ménière's disease].
    Nie GH; Lu YD
    Zhonghua Yi Xue Za Zhi; 2003 Aug; 83(15):1356-8. PubMed ID: 12930695
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intratympanic gentamicin: a 1-day protocol treatment for unilateral Meniere's disease.
    De Stefano A; Dispenza F; De Donato G; Caruso A; Taibah A; Sanna M
    Am J Otolaryngol; 2007; 28(5):289-93. PubMed ID: 17826528
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Outcomes in the use of intra-tympanic gentamicin in the treatment of Ménière's disease.
    Flanagan S; Mukherjee P; Tonkin J
    J Laryngol Otol; 2006 Feb; 120(2):98-102. PubMed ID: 16359137
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hearing results following intratympanic gentamicin perfusion for Ménière's disease.
    Kyrodimos E; Aidonis I; Sismanis A
    J Laryngol Otol; 2009 Apr; 123(4):379-82. PubMed ID: 18954493
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Transtympanic gentamicin in Ménière's disease: evaluation of the quality of life].
    Comacchio F; Martinez-Monche G; Chiappetta A; Fernandez S; Staffieri A
    Acta Otorhinolaryngol Ital; 2001 Apr; 21(2):71-6. PubMed ID: 22111129
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Intratympanic treatment in Meniere's disease: the effect of gentamicin and dexamethasone on vertigo control and hearing].
    Akkuzu B; Ozgirgin N; Ozlüoğlu LN
    Kulak Burun Bogaz Ihtis Derg; 2006; 16(5):193-9. PubMed ID: 17124437
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of intractable Menière's disease with intratympanic gentamicin: review of the University of Ottawa experience.
    Corsten M; Marsan J; Schramm D; Robichaud J
    J Otolaryngol; 1997 Dec; 26(6):361-4. PubMed ID: 9438932
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intratympanic gentamicin therapy for intractable Ménière's disease.
    De Beer L; Stokroos R; Kingma H
    Acta Otolaryngol; 2007 Jun; 127(6):605-12. PubMed ID: 17503229
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of Ménière's disease with "on-demand" intratympanic gentamicin injections.
    Manrique-Huarte R; Guillén-Grima F; Perez-Fernandez N
    Otol Neurotol; 2011 Apr; 32(3):461-5. PubMed ID: 21317673
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Menière's disease and gentamicin: preliminary results using the minimum effective dose and integrated therapy.
    Sala T
    Acta Otorhinolaryngol Ital; 2003 Apr; 23(2):78-87. PubMed ID: 14526554
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dexamethasone inner ear perfusion by intratympanic injection in unilateral Ménière's disease: a two-year prospective, placebo-controlled, double-blind, randomized trial.
    Garduño-Anaya MA; Couthino De Toledo H; Hinojosa-González R; Pane-Pianese C; Ríos-Castañeda LC
    Otolaryngol Head Neck Surg; 2005 Aug; 133(2):285-94. PubMed ID: 16087029
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intratympanic steroid injections for intractable Ménière's disease.
    Barrs DM; Keyser JS; Stallworth C; McElveen JT
    Laryngoscope; 2001 Dec; 111(12):2100-4. PubMed ID: 11802004
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term disability of class A patients with Ménière's disease after treatment with intratympanic gentamicin.
    Boleas-Aguirre MS; Sánchez-Ferrandiz N; Guillén-Grima F; Perez N
    Laryngoscope; 2007 Aug; 117(8):1474-81. PubMed ID: 17607149
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intratympanic gentamicin for control of vertigo in Meniere's disease: vestibular signs that specify completion of therapy.
    Minor LB
    Am J Otol; 1999 Mar; 20(2):209-19. PubMed ID: 10100525
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.